v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 86,508 $ 129,758
Equity method investments 4,082,998 3,612,394
Receivables, net of allowance of $55 million and $50 million, respectively 3,025,993 2,895,837
Receivables held-for-sale 43,489 75,556
Real estate and debt securities 15,903 9,802
Retained interests in securitization trusts, net of allowance of $3 million and $3 million, respectively 272,194 248,688
Other assets 69,081 108,210
Total Assets 7,596,166 7,080,245
Liabilities:    
Accounts payable, accrued expenses and other 292,074 275,639
Credit facilities 1,116 1,001
Commercial paper notes 356,197 100,057
Term loans payable 397,893 407,978
Senior unsecured notes 3,431,248 3,139,363
Convertible notes 402,531 619,543
Total Liabilities 5,007,531 4,675,170
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 123,577,987 and 118,960,353 shares issued and outstanding, respectively 1,236 1,190
Additional paid-in capital 2,723,636 2,592,964
Accumulated deficit (245,392) (297,499)
Accumulated other comprehensive income (loss) 30,738 40,101
Non-controlling interest 78,417 68,319
Total Stockholders’ Equity 2,588,635 2,405,075
Total Liabilities and Stockholders’ Equity 7,596,166 7,080,245
Non-recourse debt    
Liabilities:    
Non-recourse debt (secured by assets of $305 million and $307 million, respectively) $ 126,472 $ 131,589